ARS Corp (SPRY) Cash Money per Share

ARS Pharmaceuticals - graphic logo of issuer SPRY

ARS Pharmaceuticals employs algorithmic methods to develop innovative nasal sprays, although final trials require medical supervision. The capital expenditure minimization strategy relies on outsourcing production to third-party contractors. Meanwhile, building inventories of finished goods mitigates the risks of vendor dependency. Cash per share demonstrates financial stability, where 1.39 represents the latest level value.

ARS Pharmaceuticals, Inc. (SPRY) - Cash per Share from 04/28/2023 to 11/20/2026

Analytical breakdowns for ARS Pharmaceuticals

- share price and expert price forecast:
- cash availability and cash flow indicators:
Summary company analysis:SPRY, ARS Pharma
Flagship merchandise of ARS Pharmaceuticals, Inc.

Cash per share measures the volume of a company's liquid reserves per security, allowing for an assessment of the assets' intrinsic value and the level of financial stability. The current cash per share for ARS Pharmaceuticals (SPRY) is 1.39, which, combined with the monopoly position of the drug neffy in the anaphylaxis treatment market, confirms the high capital reliability of SPRY.

Key competitors

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|Amount of Cash per Share TBPH|Aquestive Therapeutics, Inc. - Cash per Share|scpharmaceuticals.com - Cash Calculated per Single Share|Tectonic (TECX) - Cash Funds per Share|Cash per Single Share Tonix Pharmaceuticals Inc.|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)